Patients with cardiac diseases or conditions with high risk of developing cardiac diseases
undergo risk assessment by cardiologists, primary care physicians, and scientists based on …

Heart failure (HF) affects 1–2% of the population in developed countries and~ 50% of
patients living with it are women. Compared to men, women are more likely to be older and …

Abstract Background Vest Prevention of Early Sudden Death Trial did not demonstrate a
significant reduction in arrhythmic death with the wearable cardioverter‐defibrillator (WCD) …

Simultaneous measurement of multi-physiological signals can provide effective diagnosis
and therapeutic assessment of diseases. This paper reports a carbon nanotube (CNT) …

Sympathetic neural remodeling, which involves the inflammatory response, plays an
important role in ventricular arrhythmias (VAs) after myocardial infarction (MI). Adrenergic …

Importance Despite intensive treatment, hospitalized patients with acute decompensated
heart failure (ADHF) have a substantial risk of postdischarge mortality. Limited data are …

Increased inflammation is found in cardiac sympathetic neural remodeling with malignant
ventricular arrhythmia (VA) following myocardial infarction (MI). Butyrate, as a microbiota …

Background The risk of sudden cardiac death (SCD) is high early after myocardial infarction
(MI). Current knowledge and guidelines mainly rely on results from older clinical trials and …

Myocardial infarction (MI) can result in sympathetic nerve loss in the infarct region. However,
the contribution of hypo-innervation to electrophysiological remodeling, independent from MI …

Background: The randomized DAPA trial (Defibrillator After Primary Angioplasty) aimed to
evaluate the survival benefit of prophylactic implantable cardioverter defibrillator (ICD) …